The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. J Am Acad Dermatol. 2010;62:812–8. https://doi.org/10.1016/j.jaad.2009.07.022 Article CAS PubMed Google Scholar Iyengar RL, Gandhi S, Aneja A, Thorpe K,...
22 patients with high disease activity who had no observed BASDAI improvement over 3 months, despite use of 2 consecutive NSAIDs, were included in a sub-study, and were treated with TNF-α inhibitor compounds (TNFi) for 3 months. 13 (59%) received adalimumab (40 mg/2 weeks s.c.);...
Background Adalimumab (ADA) is an effective medication in the treatment of rheumatoid arthritis (RA). However, it is not clear whether the use of ADA is associated with altered use of concomitant RA medications. Objectives To examine changes in concomitant RA medications after initiation of ADA....
Other oral drugs, includingapremilast(Otezla), azathioprine (Imuran), cyclophosphamide (Cytoxan), leflunomide (Arava),methotrexate, and sulfasalazine Biologic drugs such as abatacept, adalimumab (Humira), certolizumab (Cimzia), etanercept (Enbrel), enercept-szzs (Ereizi), golimumab (Simponi, Simponi A...
Amino acids, like leucine or phenylalanine helped to stabilize recombined IgG1 antibody (adalimumab) during spray freeze-drying and combinations of salts, sugars and amino acids were used as stabilizers to generate dry powders of antibody fragments (VR942 and CSJ117), that have been evaluated in ...
The measurement of serum soluble interleukin-2 receptor (sIL-2R), a sensitive marker of lymphocyte activation, has been proposed as an indicator of disease... M, Carotti,F, Salaffi,GF Ferraccioli,... 被引量: 0发表: 2019年 Pharmacokinetics and exposure-efficacy relationship of adalimumab in ...
adalimumab (Humira) anakinra (Kineret) baricitinib (Olumiant) certolizumab (Cimzia) etanercept (Enbrel) golimumab (Simponi) infliximab (Remicade) rituximab (Rituxan) sarilumab (Kevzara) tocilizumab (Actemra) tofacitinib (Xeljanz) Nonsteroidal anti-inflammatory drugs (NSAIDs) These medications reduce inflam...
withNSAIDs, cortisone medication (corticosteroids), or immune-modulating agents such asmethotrexate(MTX) can be the first choice. Butazathioprine,mycophenolate mofetil,cyclophosphamide, orcyclosporineare also used. Anti-TNF agents such as thebiologicsinfliximab(Remicade) oradalimumab(Humira) can also be ...
In response to the recent recommendations on the assessment of patients with spondyloarthritis, a translation is needed for health professionals Comment on: "Data to be collected for an optimal management of axial spondyloarthritis in daily practice: Proposal from evidence-based and consensual approaches...
Crohn’s disease is a chronic disease caused by inflammation in the digestive tract. Symptoms can range from mild to severe, but they usually develop gradually. If you see persistent changes in your bowel movements, consider a visit to your provider. Whi